Previous 10 | Next 10 |
Equillium (EQ) traded 2.7% higher premarket on entering into a securities purchase agreement with life science institutional investment funds managed by Decheng Capital, to purchase 4,285,710 units from Equillium; each unit consisting of one share and a warrant to purchase 0.3 ...
ATA Creativity Global (AACG) +163%.Anavex Life Sciences (AVXL) +83%.Profire Energy (PFIE) +57%.Theratechnologies (THTX) +56% on FDA fast track designation for the treatment of Sortilin-expressing Cancers.Cyclerion Therapeutics (CYCN) +34%.Atossa Therapeutics (ATOS) +33%.Enservco Corporat...
LA JOLLA, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that it has entered into a securities purchase agreement with life science ins...
LA JOLLA, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that interim data from the Phase 1b/2 EQUATE study of itolizumab in acute graf...
LA JOLLA, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that Bruce Steel, Equillium’s chief executive officer, will present at ...
Gainers: Bionano Genomics (BNGO) +82%, DermTech (DMTK) +25%, IMAC Holdings (IMAC) +20%, Gritstone Oncology (GRTS) +15%, Hepion Pharmaceuticals (HEPA) +12%.Losers: Regional Health Properties (RHE) -20%, Osmotica Pharmaceuticals (OSMT) -20%, Equ...
Osmotica Pharmaceuticals OSMT -26% on FDA response letter.Big Rock Partners Acquisition (BRPA) -25%.Regional Health Properties (RHE) -18%.Gevo (GEVO) -15%.New Concept Energy (GBR) -15%.MoSys (MOSY) -13%.Oxbridge Re Holdings (OXBR) -10%.IRIDEX (IRIX) -10%.Equillium (EQ) -10%.Tenax Th...
Gainers: [[CNFR]] +90.6%. [[IMMP]] +8.5%. [[NGL]] +4.4%. [[CHMA]] +3.8%. [[MDU]] +3.6%.Losers: [[JRJC]] -10.0%. [[GBR]] -7.4%. [[ACY]] -6.4%. [[EQ]] -4.5%. [[IRIX]] -4.1%. For further details see: CNFR, ACY, IMMP, and JRJC among after-hours movers
LA JOLLA, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced the appointment of Dolca Thomas, M.D., as its executive vice president of rese...
LA JOLLA, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, presented data over the weekend demonstrating the impact of itolizumab on effector T cell func...
News, Short Squeeze, Breakout and More Instantly...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will be participating in the Leerink Partners Therapeutic Forum: I&I and Metabolism, as well as the Jone...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it expects to join the Russell Microcap Index at the conclusion of the 2024 Russell annual reconstitution, effe...
A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 74.6% to $0.46 on volume of 265,324,361 shares MicroAlgo Inc. (MLGO) rose 669.9% to $12.01 on volume of 183,977,846 shares PROSHARES TRUST (SQQQ) fell 0.7% to $9.86 on volume of 124,114,596 shares Faraday ...